CAR T-Cell Therapy_990x120
watch on demand (2)
If you have already registered, follow this link and click on "Already Registered?" to enter your email address and view the webinar.

Event Overview

Following the success of the first checkpoint inhibitors for treating cancer, many researchers are now turning their attention to chimeric antigen receptor (CAR) T cell therapy. This novel treatment makes use of a cancer patient’s own T cells, which are removed and modified so that they can better recognize and attack cancer cells. These modified cells are then infused back into the patient’s body. While this approach has shown some success for certain cancers, severe toxicities have limited its widespread application. Researchers are attempting different methods to overcome these toxic effects, including using gene-editing tools such as CRISPR to modify CAR T cell protein production and employing antibody therapy to potentially block toxicity-inducing proteins. Will CAR T cell therapy emerge as a game changer for cancer treatment? Or are the hurdles too high? Join The Scientist for an educational webinar, sponsored by Enzo, Nanostring, Sartorius, and IsoPlexis as we explore CAR T cell therapy research and gain insight into the next steps.

Topics to be Covered
  • Diagnosing and managing CAR T cell therapy-related toxicities
  • Identifying early predictive toxicity markers in patients treated with CAR T cell therapy
Monday, December 2, 2019
2:30 - 4:00 PM, Eastern Time


David T. Teachey, MD
Associate Professor of Pediatrics
Children's Hospital of Philadelphia Department of Pediatrics Perelman School of Medicine at the University of Pennsylvania

Rawan Faramand, MD
Assistant Member, Blood and Marrow Transplant & Cellular Immunotherapy
H. Lee Moffitt Cancer Center and Research Institute




Register Now

CAR T-Cell Therapy: Overcoming Toxicities

You must have Javascript and Cookies enabled to access this webcast.

Information you provide will be held in confidence and will be shared with the sponsoring vendor(s) of this webinar. We may use the information to contact you about your account and to let you know about related programs and products; you may opt-out at any time. This allows The Scientist to keep these webinars free of charge for our readers.